PSA LEVEL AND ADVERSE EVENTS IN SIXTH AND TENTH SERIES DOCETAXEL CHEMOTHERAPY IN CASTRATE-RESISTANT PROSTATE CANCER (CRPC) PATIENTS
Objective: This study aims to compare the efficacy of docetaxel on PSA levels and to analyze the adverse events caused by docetaxel. Material & Methods: The study design was retrospective cohort. Participants were prostate cancer patients at Saiful Anwar Hospital who received androgen deprivati...
Saved in:
Main Authors: | Kurnia Penta Seputra, Andri Kustono, Muhammad Baihaqy Ibnu Hakim |
---|---|
Format: | Article |
Language: | English |
Published: |
IKATAN AHLI UROLOGI INDONESIA
2025-01-01
|
Series: | Jurnal Urologi Indonesia |
Subjects: | |
Online Access: | http://juri.urologi.or.id/juri/article/view/917 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with castration-resistant prostate cancer treated with docetaxel-based chemotherapy: a meta-analysis
by: Ying Zhang, et al.
Published: (2025-01-01) -
DRG2 levels in prostate cancer cell lines predict response to PARP inhibitor during docetaxel treatment
by: Jeong Min Lee, et al.
Published: (2025-01-01) -
ABA enhances the apoptotic effect of docetaxel in the multidrug-resistant DU145 prostate cancer cell line
by: Şumnulu Deniz, et al.
Published: (2024-01-01) -
Enhancing in Vitro anti-metastatic efficacy and deep penetration into tumor spheroid of docetaxel-loaded liposomes via size optimization for prostate cancer treatment
by: Saksorn Klibaim, et al.
Published: (2025-03-01) -
PSA is not suitable as a reliable marker for seminal fluid in rectal samples collected post-mortem
by: Corine Müller, et al.
Published: (2025-07-01)